Inventor · disambiguated record
Sirpa Jalkanen
Also filed as: JALKANEN SIRPA
14 granted patents·9 pending applications·84 citations·filing 1994–2021
90Inventor score
Files withFARON PHARMACEUTICALS OY10JALKANEN SIRPA5FARON PHARMACEUTICALS OY A FIN1FARON PHARMACEUTICALS OY a Finnish company1FARON VENTURES OY1
Top patents by PatentIndex Score
23 records- 0179US7910097B2Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereofFARON PHARMACEUTICALS OY·Filed 2008·Granted Mar 22, 2011·5 cites·13 claims
- 0278US8975081B2Biomarker for monitoring development of diseases and assessing the efficacy of therapiesFARON PHARMACEUTICALS OY·Filed 2013·Granted Mar 10, 2015·2 cites·4 claims
- 0376US5616468ACompositions and diagnostic methods using monoclonal antibodies against CD44v6Filed 1995·Granted Apr 1, 1997·30 cites·14 claims
- 0471US7534423B2Method for inducing an elevated level of adenosine in an individualFARON PHARMACEUTICALS OY·Filed 2004·Granted May 19, 2009·4 cites·10 claims
- 0569US7354577B2Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereofFARON PHARMACEUTICALS OY·Filed 2003·Granted Apr 8, 2008·5 cites·7 claims
- 0666US10247730B2Method for determining acute respiratory distress syndrome (ARDS) related biomarkers, a method to monitor the development and treatment of ARDS in a patientFARON PHARMACEUTICALS OY·Filed 2014·Granted Apr 2, 2019·1 cites·15 claims
- 0765US6066321AMethod for antagonizing vascular adhesion protein-1 (VAP-1)-mediated binding of endothelial cells to lymphocytesFiled 1995·Granted May 23, 2000·13 cites·10 claims
- 0865US5580780AVascular adhesion protein-(VAP-1) and VAP-1-specific antibodiesFiled 1994·Granted Dec 3, 1996·18 cites·21 claims
- 0962US2009269303A1Method for treating or preventing conditions by elevation of the adenosine level in an individualFARON PHARMACEUTICALS OY·Filed 2009·Application pending·0 cites
- 1059US2007191408A1Compositions useful especially for treatment or prevention of metabolic syndromeFARON PHARMACEUTICALS OY·Filed 2006·Application pending·0 cites
- 1157US7727521B2Method of ameliorating multi-organ failure resulting from ischemic reperfusion injuryFARON PHARMACEUTICALS OY·Filed 2005·Granted Jun 1, 2010·0 cites·6 claims
- 1256US2023046617A1Method for promoting expansion of hematopoietic stem cells and agent for use in the methodFARON PHARMACEUTICALS OY·Filed 2021·Application pending·0 cites
- 1355US8119651B2Compositions useful especially for treatment or prevention of metabolic syndromeJALKANEN SIRPA·Filed 2008·Granted Feb 21, 2012·0 cites·5 claims
- 1453US10526607B2Cell and therapeutical and diagnostical methods based thereonFARON PHARMACEUTICALS OY·Filed 2014·Granted Jan 7, 2020·0 cites·6 claims
- 1551US2010310579A1Method for inhibiting angiogenesis or for treatment of cancerFARON VENTURES OY·Filed 2008·Application pending·0 cites
- 1649US2010209942A1New biomarker for monitoring development of diseases and assessing the efficacy of therapiesFARON PHARMACEUTICALS OY A FIN·Filed 2008·Application pending·0 cites
- 1748US5512442ADetection of vascular adhesion protein-1 (VAP-1)Filed 1995·Granted Apr 30, 1996·6 cites·21 claims
- 1848US2008213176A1Compositions for Targeting Amine Oxidases in VivoJALKANEN SIRPA·Filed 2006·Application pending·0 cites
- 1943US8722045B2Cell and therapeutical and diagnostical methods based thereonJALKANEN SIRPA·Filed 2010·Granted May 13, 2014·0 cites·2 claims
- 2042US2007093433A1Aminoglycoside antibiotics for use as vap-1/ssao inhibitorsJALKANEN SIRPA·Filed 2004·Application pending·0 cites
- 2141US2012115815A1Compositions useful especially for treatment or prevention of metabolic syndromeJALKANEN SIRPA·Filed 2012·Application pending·0 cites
- 2239US2011038922A1Compounds for treating or preventing amine oxidase related diseases or disordersFARON PHARMACEUTICALS OY a Finnish company·Filed 2006·Application pending·0 cites
- 2338US8138151B2PeptidesKIVI ELINA·Filed 2007·Granted Mar 20, 2012·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Sirpa Jalkanen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →